What do you think are the top 10 most promising healthcare innovations for 2015? (Poll Closed)
Use of “Big data” to reduce the costs for high-cost patients
7%
Financial incentivizing of healthy behavior by employers
6%
Innovations for managing outpatient behavioral health
6%
Better reimbursement for telemedicine leading to greater use of telehealth and digital health by clinicians in their day to day practice
5%
Health care delivery goes retail to increase patient engagement
5%
Decreased healthcare costs as cost transparency and competition increases
5%
The use of “wearables” increasing in hospitals to detect continuous biomarkers
5%
Increased prescription of health apps
4%
Care delivery innovation for end-of- life care patients
4%
Better care delivery and engagement for the large number of newly insured and millennials
4%
Increased use of 3-D printing
4%
Sequencing the microbiome to create novel cures for disease
4%
The development of the breast cancer vaccine
3%
Selective targeting of cancer cells via antibody-drug conjugates as an alternative to chemotherapy
3%
Scope of practice will expand as more health consumers voice that they are equally comfortable seeing NP or PA as MD
3%
Genome editing proteins – molecules that can be programmed to alter specific genes to treat or perhaps cure genetic diseases
3%
Engagement of family caregivers for increased caregiver support and better patient care coordination
3%
Tumor profiling – personalizing treatment for breast cancer
3%
The use of non-contact devices to monitor patients will detect decompensation earlier
3%
Messenger RNA (mRNA) therapies to develop vaccines and treatments
2%
Data visualization with virtual reality, models and holograms will help patients and consumers make meaningful sense of data like vital signs and biomarkers
2%
Progress in gene therapy
2%
Acceleration of large employers securing deals with major health systems to provide bundled, efficient services to employees
2%
Discovery of Teixobactin will pave the way for new class of antibiotics with no resistance
2%
Real-time locating systems enabling more efficient use of devices and reducing provider time
2%
Pharmaceutical companies will continue to collaborate with stakeholders earlier in the R&D cycle. Use of CROs will grow significantly
2%
Growth in narrow networks, high deductibles, and price transparency will lead patients to be more active in choosing and directing their care
2%
New privacy and security reinforcements as more and more data becomes transparent
2%
Diagnostics for Alzheimer’s disease
2%
Innovation in care delivery systems and management modalities for ‘dual eligibles’ (Medicare and Medicaid)
2%
Other
0%
See this poll on:
https://poll.fm/8605193/embed
closed
